R. Schwabe

T. Luedde, R. Schwabe, D. Brenner, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice

R. Schwabe, A. Kannt, K. Jahn-Hofmann, 2019, Hepatology communications.

Inhibition of carnitine palmitoyl-transferase 1A in hepatic stellate cells protects against fibrosis.

R. Schwabe, D. Serra, M. Schwaninger, 2022, Journal of hepatology.

Regulation of TNF-α- and Fas-Induced Hepatic Apoptosis by NF-κB

R. Schwabe, D. Brenner, E. Hatano, 2002 .

Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis.

R. Schwabe, Xiaoming Yang, K. Guan, 2020, Cell metabolism.

TRAIL‐mediated apoptosis requires NF‐kB inhibition and the mitochondrial permeability transition in human hepatoma cells

R. Schwabe, D. Brenner, J. Lemasters, 2002 .

NLR Family Pyrin Domain‐Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice

R. Schwabe, C. Trautwein, A. Wree, 2019, Hepatology.

Mechanisms of Fibrosis Development in NASH.

R. Schwabe, I. Tabas, U. Pajvani, 2020, Gastroenterology.

Effect of age and cognitive status on basal level AP-1 activity in rat hippocampus

D. R. Smith, R. Schwabe, M. Gallagher, 2001, Neurobiology of Aging.

c‐Jun‐N‐terminal kinase drives cyclin D1 expression and proliferation during liver regeneration

R. Schwabe, D. Brenner, E. Hatano, 2003, Hepatology.

Macrophage‐derived HMGB1 is dispensable for tissue fibrogenesis

R. Schwabe, C. Dray, P. Valet, 2019, FASEB bioAdvances.

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications

R. Schwabe, V. Mazzaferro, S. Friedman, 2022, Gut.

Prevention and treatment of hepatic fibrosis at the cellular level

R. Schwabe, B. Stefanovic, R. Bataller, 2004 .

Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.

R. Schwabe, B. Stockwell, A. Califano, 2021, Cancer cell.

Autophagy and hepatic stellate cell activation - partners in crime?

R. Schwabe, Christine C Hsu, Christine C. Hsu, 2011, Journal of hepatology.

Fatty Acid Amide Hydrolase Determines Anandamide-induced Cell Death in the Liver*

R. Schwabe, B. Cravatt, Y. Osawa, 2006, Journal of Biological Chemistry.

Anandamide induces necrosis in primary hepatic stellate cells

R. Schwabe, D. Brenner, Y. Osawa, 2005, Hepatology.

Liver specific, systemic and genetic contributors to alcohol-related liver disease progression.

R. Schwabe, J. Hengstler, A. Ghallab, 2022, Zeitschrift fur Gastroenterologie.

Origin and Function of Myofibroblasts in the Liver

R. Schwabe, R. Wells, 2015, Seminars in Liver Disease.

Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation

R. Schwabe, D. Brenner, M. Adachi, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Mechanisms by which TLR4 and endotoxin promote hepatocellular carcinoma require further investigation

R. Schwabe, G. Gwak, A. Mencin, 2011, Hepatology.

Modulation of soluble CD40 ligand bioactivity with anti-CD40 antibodies.

R. Schwabe, J. Johnson, H. Engelmann, 1997, Hybridoma.

Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome

Christian M. Metallo, R. Schwabe, S. Rosenthal, 2022, Nature.

Mouse model of NASH that replicates key features of the human disease and progresses to fibrosis stage 3

R. Schwabe, D. Saxena, J. Caviglia, 2022, Hepatology communications.

Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis

R. Schwabe, J. Zucman‐Rossi, M. Karin, 2022, Nature.

ene Expression Profiles During Hepatic Stellate Cell Activation in ulture and In Vivo

R. Schwabe, H. Uchinami, E. Seki, 2007 .

Animal models of HCC - When injury meets mutation.

R. Schwabe, J. Caviglia, Jun Yan, 2017, Journal of hepatology.

High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo.

R. Schwabe, M. Czaja, R. Friedman, 2014, Cell metabolism.

Loss of heat shock factor 1 promotes hepatic stellate cell activation and drives liver fibrosis

C. L. Moore, R. Schwabe, P. Mandrekar, 2022, Hepatology communications.

NF-κB-inducing kinase restores defective IκB kinase activity and NF-κB signaling in intestinal epithelial cells

R. Schwabe, M. Russo, R. Sartor, 2004 .

Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH)

R. Schwabe, R. Bataller, M. Poca, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Toll-like receptor signaling in the liver.

R. Schwabe, D. Brenner, E. Seki, 2006, Gastroenterology.

Gut microbiota and Toll-like receptors set the stage for cytokine-mediated failure of antibacterial responses in the fibrotic liver

R. Schwabe, C. Kuntzen, 2016, Gut.

Leukocyte-derived High-mobility group box 1 controls innate immune responses against Listeria monocytogenes

R. Schwabe, M. Nishibori, A. Lohse, 2019 .

Activated Human Hepatic Stellate Cells Kinase and Enhances Chemokine Secretion on B and c-Jun N-Terminal κ CD40 Activates NF-

R. Schwabe, D. Brenner, Y. Kweon, 2011 .

Hypoxia and hypoxia‐inducible factor 1α: potential links between angiogenesis and fibrogenesis in hepatic stellate cells

R. Schwabe, Juliane S. Troeger, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Chimeric Antigen Receptor T Cells as Senolytic and Antifibrotic Therapy

R. Schwabe, Aashreya Ravichandra, A. Filliol, 2021 .

Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.

R. Schwabe, R. Birge, R. Chung, 2019, Cell metabolism.

Mouse Models of Liver Fibrosis.

R. Schwabe, Aashreya Ravichandra, 2021, Methods in molecular biology.

Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis

R. Schwabe, R. Friedman, G. Gwak, 2016, Gut.

The endocannabinoid 2‐arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

R. Schwabe, K. Vinod, G. Kunos, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Roles for C 16-ceramide and Sphingosine 1-Phosphate in Regulating Hepatocyte Apoptosis in Response to Tumor Necrosis Factor-* □

R. Schwabe, D. Brenner, Y. Hannun, 2005 .

Liver cancer metabolism: a hexokinase from the stars

R. Schwabe, A. Filliol, 2022, Nature Metabolism.

Cell death in the liver-all roads lead to JNK.

R. Schwabe, 2006, Gastroenterology.

TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.

R. Schwabe, E. Verna, I. Tabas, 2021, Journal of hepatology.

TLR4 enhances TGF-beta signaling and hepatic fibrosis.

R. Schwabe, D. Brenner, Y. Osawa, 2007, Nature medicine.

CD40 function in nonhematopoietic cells. Nuclear factor kappa B mobilization and induction of IL-6 production.

R. Schwabe, H. Engelmann, P. Bufler, 1995, Journal of immunology.

Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

R. Schwabe, D. Brenner, H. Uchinami, 2007, Gastroenterology.

The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver

R. Schwabe, Céline Hernandez, P. Huebener, 2022, Science Translational Medicine.

Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.

R. Schwabe, B. Stockwell, A. Califano, 2021, Cancer cell.

Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

R. Schwabe, KyeongJin Kim, M. Graham, 2018, Science Translational Medicine.

Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration.

Ramon Bataller, R. Schwabe, D. Brenner, 2003, American journal of physiology. Gastrointestinal and liver physiology.

Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage.

R. Schwabe, E. Hillman, W. Blaner, 2009, Biochimica et biophysica acta.

Regulation of wound healing and organ fibrosis by toll-like receptors.

R. Schwabe, P. Huebener, 2013, Biochimica et biophysica acta.

Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells

T. Luedde, R. Schwabe, M. Manns, 2007, Digestive Diseases and Sciences.

Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells

R. Schwabe, D. Brenner, E. Seki, 2008, Hepatology.

The gut microbiome and liver cancer: mechanisms and clinical translation

R. Schwabe, Le-xing Yu, Le-Xing Yu, 2017, Nature Reviews Gastroenterology &Hepatology.

CCR2 promotes hepatic fibrosis in mice

R. Schwabe, D. Brenner, N. Van Rooijen, 2009, Hepatology.

The Yin and Yang of Toll-like receptors in cancer

R. Schwabe, J. Pradère, D. Dapito, 2014, Oncogene.

Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts.

R. Schwabe, R. Kalluri, P. Sims, 2021, The Journal of clinical investigation.

Immunology and immunotherapy of cholangiocarcinoma

R. Schwabe, T. Greten, N. Bardeesy, 2023, Nature Reviews Gastroenterology & Hepatology.

EMT is not required for lung metastasis but contributes to chemoresistance

Stephen T. C. Wong, R. Schwabe, J. Sheng, 2015, Nature.

Roles for C16-ceramide and Sphingosine 1-Phosphate in Regulating Hepatocyte Apoptosis in Response to Tumor Necrosis Factor-α*

R. Schwabe, D. Brenner, Y. Hannun, 2005, Journal of Biological Chemistry.

Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways

David A. Brenner, R. Schwabe, D. Brenner, 2006 .

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

R. Schwabe, D. Brenner, R. Bataller, 2003, The Journal of clinical investigation.

Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes

R. Schwabe, J. W. Wiley, 2022 .

MicroRNA‐21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis

R. Schwabe, P. Olinga, Xin Chen, 2018, Hepatology.

REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance

T. Luedde, R. Schwabe, N. Kaplowitz, 2014 .

Damage-associated molecular patterns in cancer: A double-edged sword

R. Schwabe, Céline Hernandez, P. Huebener, 2016, Oncogene.

A molecular single-cell lung atlas of lethal COVID-19

André F. Rendeiro, Xinzheng V. Guo, Daniel T. Montoro, 2021, Nature.

Focal Adhesion Kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation.

R. Schwabe, D. Calvisi, Xin Chen, 2021, Journal of hepatology.

The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.

R. Schwabe, Silvia Affò, Le-xing Yu, 2017, Annual review of pathology.

Gremlin 1 Identifies a Skeletal Stem Cell with Bone, Cartilage, and Reticular Stromal Potential

Jocelyn T. Compton, R. Schwabe, A. Rustgi, 2015, Cell.

Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.

R. Schwabe, R. Friedman, J. Pradère, 2016, Gastroenterology.

Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

R. Schwabe, D. Brenner, J. Segovia, 2006, Journal of hepatology.

EMT is not required for lung metastasis but contributes to chemoresistance

Stephen T. C. Wong, R. Schwabe, J. Sheng, 2016 .

Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis

Shelly C. Lu, R. Schwabe, M. Sweet, 2019, Science Translational Medicine.

TLR4 enhances TGF-β signaling and hepatic fibrosis

Yosuke Osawa, R. Schwabe, D. Brenner, 2007, Nature Medicine.

Differential requirement for c‐Jun NH2‐terminal kinase in TNF‐α‐and Fas‐mediated apoptosis in hepatocytes

R. Schwabe, D. Brenner, H. Uchinami, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

HMGB1 and injury amplification

R. Schwabe, Céline Hernandez, P. Huebener, 2015, Oncotarget.

Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice

R. Schwabe, R. Friedman, G. Gwak, 2013, Hepatology.

Differential role of IκB kinase 1 and 2 in primary rat hepatocytes

R. Schwabe, D. Brenner, A. Manning, 2001 .

Fate-tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology

R. Schwabe, P. Huebener, J. Pradère, 2013, Nature Communications.

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

Raul Rabadan, Ramon Bataller, Hossein Khiabanian, 2012, Cancer cell.

Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.

R. Schwabe, S. Lowe, Ju-Seog Lee, 2020, Journal of hepatology.

Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes

David A. Brenner, R. Schwabe, D. Brenner, 2002 .

Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.

R. Schwabe, R. Chung, J. Caviglia, 2016, Cell metabolism.

CCR1 and CCR5 promote hepatic fibrosis in mice.

R. Schwabe, D. Brenner, J. Llovet, 2009, The Journal of clinical investigation.

Genetic dissection of retinoid esterification and accumulation in the liver and adipose tissue

R. Schwabe, W. Blaner, I. Goldberg, 2014, Journal of Lipid Research.

Contribution of Underlying Connective Tissue Cells to Taste Buds in Mouse Tongue and Soft Palate

R. Schwabe, Nandakumar Venkatesan, Y. Mishina, 2016, PloS one.

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

R. Schwabe, Céline Hernandez, G. Gwak, 2019, The Journal of clinical investigation.

Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis

R. Schwabe, A. Filliol, 2019, Seminars in Liver Disease.

In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis.

R. Schwabe, D. Grimm, Laure Dumont, 2016, Cell stem cell.

CD40 Activates NF-κB and c-Jun N-Terminal Kinase and Enhances Chemokine Secretion on Activated Human Hepatic Stellate Cells1

R. Schwabe, D. Brenner, Y. Kweon, 2001, The Journal of Immunology.

Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.

R. Schwabe, F. Tacke, P. Kubes, 2022, Journal of hepatology.

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

R. Schwabe, Céline Hernandez, R. Friedman, 2019, The Journal of clinical investigation.

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis

R. Schwabe, Céline Hernandez, R. Friedman, 2019, The Journal of clinical investigation.

TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver

R. Schwabe, F. Lammert, D. Dapito, 2016, PloS one.

Toll-like receptors, wound healing, and carcinogenesis

R. Schwabe, J. Kluwe, A. Mencin, 2009, Journal of Molecular Medicine.

Toll‐Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

Christian Jobin, R. Schwabe, D. Brenner, 2003, Hepatology.

Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis.

R. Schwabe, D. Brenner, A. Tall, 2005, The Journal of biological chemistry.

c‐Jun NH2‐terminal kinases in liver diseases

R. Schwabe, J. Kluwe, 2015 .

JNKs in liver diseases

R. Schwabe, 2010 .

Transforming Growth Factor- (cid:1) 1 Inhibits Non-pathogenic Gram-negative Bacteria-induced NF- (cid:2) B Recruitment to the Interleukin-6 Gene Promoter in Intestinal Epithelial Cells through Modulation of Histone Acetylation*

R. Schwabe, D. Haller, R. Sartor, 2022 .

Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.

R. Schwabe, R. Bataller, G. Gwak, 2010, Gastroenterology.

Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways.

R. Schwabe, D. Brenner, Robert F Schwabe, 2006, American journal of physiology. Gastrointestinal and liver physiology.

Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

R. Schwabe, R. Friedman, G. Gwak, 2012, Gastroenterology.

Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis

R. Schwabe, D. Brenner, Y. Paik, 2010, Hepatology.

Regenerating research and life

R. Schwabe, 2020, JHEP Reports.

c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis

R. Schwabe, M. Karsdal, P. Carmeliet, 2020, Nature Metabolism.

Nuclear Factor-κB in the Liver: Friend or Foe?

R. Schwabe, D. Brenner, 2007 .

Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.

R. Schwabe, Da Yang, S. Monga, 2019, Gastroenterology.

Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment.

R. Schwabe, C. Sempoux, I. Leclercq, 2015, The Journal of clinical investigation.

Mouse models of liver cancer.

R. Schwabe, J. Caviglia, 2015, Methods in molecular biology.

β-Catenin sustains and is required for YES-associated protein oncogenic activity in cholangiocarcinoma.

R. Schwabe, D. Calvisi, Sungjin Ko, 2022, Gastroenterology.

Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.

R. Schwabe, S. Siegmund, 2008, American journal of physiology. Gastrointestinal and liver physiology.

Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells

R. Schwabe, C. Strassburg, H. Uchinami, 2016, PloS one.

Targeting liver cancer: first steps toward a miRacle?

Timothy C Wang, R. Schwabe, T. Wang, 2011, Cancer cell.

Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth

R. Schwabe, H. Rui, Yongsheng Li, 2021, Cancer Research.

Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor

R. Schwabe, W. Wahli, H. Guillou, 2022, Science advances.

Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor

R. Schwabe, W. Wahli, H. Guillou, 2021, bioRxiv.

Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.

R. Schwabe, D. Brenner, Robert F Schwabe, 2002, American journal of physiology. Gastrointestinal and liver physiology.

Author Correction: A molecular single-cell lung atlas of lethal COVID-19

Xinzheng V. Guo, Daniel T. Montoro, R. Schwabe, 2021, Nature.

Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes.

R. Schwabe, D. Brenner, A. Manning, 2001, Hepatology.

EFFECTS OF THREE SUPEROXIDE DISMUTASE GENES DELIVERED WITH AN ADENOVIRUS ON GRAFT FUNCTION AFTER TRANSPLANTATION OF FATTY LIVERS IN THE RAT1

R. Schwabe, D. Brenner, J. Samulski, 2003, Transplantation.

Neuropilin and liver fibrosis: Hitting three birds with one stone?

R. Schwabe, Juliane S. Troeger, 2011, Hepatology.

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

R. Schwabe, Céline Hernandez, R. Friedman, 2019, Journal of Clinical Investigation.

Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis.

R. Schwabe, G. Vicent, Eunjeong Kim, 2021, Journal of hepatology.

Tgf-B1-activated SMAD signaling inhibits non-pathogenic gram negative bacteria-induced Nf-Kb recruitment to the Il-6 gene promoter through modulation of histone acetylation in intestinal epithelial cells

R. Schwabe, D. Haller, R. Sartor, 2003 .

Nuclear factor-kappaB in the liver: friend or foe?

R. Schwabe, D. Brenner, 2007, Gastroenterology.

Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis

R. Schwabe, W. Blaner, G. Gwak, 2011, Gut.

Liver Fibrosis

R. Schwabe, R. Bataller, 2015, Seminars in Liver Disease.

Amendment history : Corrigendum ( March 2019 ) Expression of Concern ( March 2019 ) The HMGB 1 / RAGE axis triggers neutrophil-mediated injury amplification following necrosis

R. Schwabe, Céline Hernandez, G. Gwak, 2019 .

Enterohepatic shunt-driven cholemia predisposes to liver cancer.

R. Schwabe, D. Albanes, S. Weinstein, 2022, Gastroenterology.

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

R. Schwabe, Céline Hernandez, R. Friedman, 2019, The Journal of clinical investigation.

High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo.

R. Schwabe, M. Czaja, R. Friedman, 2014, Cell metabolism.

Cell death and cell death responses in liver disease: mechanisms and clinical relevance.

T. Luedde, R. Schwabe, N. Kaplowitz, 2014, Gastroenterology.

REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance

T. Luedde, R. Schwabe, N. Kaplowitz, 2014 .

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

R. Schwabe, Céline Hernandez, G. Gwak, 2019, The Journal of clinical investigation.

Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice

R. Schwabe, R. Friedman, G. Gwak, 2013, Hepatology.

FoxM1 Induces CCl2 Secretion From Hepatocytes Triggering Hepatic Inflammation, Injury, Fibrosis, and Liver Cancer

R. Schwabe, A. Filliol, 2020, Cellular and molecular gastroenterology and hepatology.

Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis

Shelly C. Lu, R. Schwabe, M. Sweet, 2019, Science Translational Medicine.

Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis

R. Schwabe, W. Blaner, G. Gwak, 2011, Gut.

Lipids in liver disease: looking beyond steatosis.

R. Schwabe, J. Maher, 2012, Gastroenterology.

Hypoxia and hypoxia‐inducible factor 1α: potential links between angiogenesis and fibrogenesis in hepatic stellate cells

R. Schwabe, Juliane S. Troeger, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Origin and Function of Myofibroblasts in the Liver

R. Schwabe, R. Wells, 2015, Seminars in Liver Disease.